Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

RXSTVery BearishCorporate Developmentsnews

High materiality10/10

Crude Oil Moves Higher; RxSight Shares Plunge

Jul 9, 2025, 1:57 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The significant revenue guidance cut signals adverse financial performance, leading to a sharp stock drop. Historical precedents show similar revenue reductions often negatively impact stock prices due to investor sentiment and trust erosion.

AI summary

What happened, with direct paths to the underlying reporting

RXST shares fell 42% to $7.39 after revenue guidance cut. 2025 revenue outlook changed from $160M-$175M to $120M-$130M. Overall stock market saw mixed movements with Nasdaq gaining over 100 points. U.S. crude oil inventories saw the largest increase since January. Other companies like Calidi and Evoke Pharma surged on positive announcements.

RXST shares fell 42% to $7.39 after revenue guidance cut.
2025 revenue outlook changed from $160M-$175M to $120M-$130M.
Overall stock market saw mixed movements with Nasdaq gaining over 100 points.
U.S. crude oil inventories saw the largest increase since January.
Other companies like Calidi and Evoke Pharma surged on positive announcements.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.